Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,240 | -34,524 | -30,092 | -38,849 | -53,302 |
| Depreciation Amortization | 554 | 3,362 | 3,054 | 2,692 | 2,394 |
| Accounts receivable | N/A | N/A | N/A | N/A | 20 |
| Accounts payable and accrued liabilities | -1,490 | -1,332 | -6,714 | 5,727 | -5,326 |
| Other Working Capital | -1,270 | -13,195 | -13,682 | 11,163 | -7,052 |
| Other Operating Activity | 5,655 | 13,398 | 14,394 | 3,762 | 17,784 |
| Operating Cash Flow | $-31,790 | $-32,290 | $-33,040 | $-15,505 | $-45,483 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -900 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -437 | -2,781 | -292 | -1,098 |
| Investing Cash Flow | $-900 | $-437 | $-2,781 | $-292 | $-1,098 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 15,000 | 0 |
| Debt Issued | 904 | N/A | N/A | N/A | 200 |
| Debt Repayment | -263 | -6,944 | -991 | -3,669 | -13,545 |
| Common Stock Issued | 36,570 | 45,969 | 14,695 | 1,861 | 53,213 |
| Other Financing Activity | 0 | 0 | 20,648 | 3,439 | -6 |
| Financing Cash Flow | $37,211 | $39,025 | $34,353 | $16,631 | $39,862 |
| Beginning Cash Position | 8,016 | 1,717 | 3,186 | 2,352 | 9,071 |
| End Cash Position | 12,536 | 8,016 | 1,717 | 3,186 | 2,352 |
| Net Cash Flow | $4,521 | $6,298 | $-1,468 | $834 | $-6,719 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,790 | -32,290 | -33,040 | -15,505 | -45,483 |
| Capital Expenditure | N/A | -437 | -2,781 | -292 | -1,098 |
| Free Cash Flow | -31,790 | -32,727 | -35,821 | -15,797 | -46,581 |